Agilent Technologies Inc vs ProShares UltraPro QQQ ETF — how do they compare? Agilent Technologies Inc trades at $148.76 (market cap $42.22B), while ProShares UltraPro QQQ ETF trades at $74.65. The key difference: Agilent Technologies Inc pays a 0.68% dividend while ProShares UltraPro QQQ ETF pays none. Which is the better fit depends on your goals.
| A | TQQQ | |
|---|---|---|
Market Cap | $42.22B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $157.20 | $87.22 |
52-Week Low | $110.24 | $37.89 |
Enterprise Value | $43.77B | — |
Dividend Yield | 0.68% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $148.72, up 1.88% with strong analyst support (77.5% buy ratings). The stock shows bullish technical momentum above key support levels, supported by consistent revenue around $6.9B and robust profitability with 19.55% net margins. Recent FDA approvals for diagnostic tests and the Biocare Medical acquisition enhance growth prospects in biopharma markets.
Outlook remains positive with a $154.90 consensus price target offering 4% upside, though high P/E of 30.02 poses valuation risk. Key catalysts include Q2 2026 earnings due August 26 and AI-driven lab expansion, while overbought RSI levels near 92 suggest near-term consolidation potential.
TQQQ trades at $74.96, up 1.59% with a bullish technical signal supported by moving averages. The leveraged ETF shows strong momentum from AI-driven tech sector performance, though oscillators indicate neutral short-term sentiment. Recent institutional buying activity and positive media coverage highlight continued investor interest in Nasdaq-100 exposure through this 3x leveraged vehicle.
The outlook remains positive given robust tech earnings and AI infrastructure spending, but volatility decay and leverage risks require careful position sizing. TQQQ offers amplified Nasdaq-100 returns during bull markets but faces significant downside risk during market corrections, making it suitable for tactical rather than long-term holdings.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →